[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100384372":3},{"organization":4,"outcomesModule":7,"designInfo":69,"detailedDescription":75,"studyPopulation":16,"armGroups":76,"interventions":89,"overallOfficials":105,"centralContacts":110,"locations":119,"responsibleParty":359,"collaborators":361,"id":364,"slug":16,"hasResults":365,"nctId":366,"briefTitle":367,"officialTitle":367,"acronym":368,"eligibilityCriteria":369,"healthyVolunteers":365,"sex":370,"minAge":371,"maxAge":16,"enrollmentInfo":372,"targetDuration":16,"studyType":375,"phases":376,"briefSummary":378,"conditions":379,"keywords":382,"overallStatus":122,"whyStopped":16,"lastUpdateSubmitDate":385,"lastUpdatePostDateStruct":386,"startDateStruct":389,"completionDateStruct":391,"leadSponsor":393,"locationsCount":394},{"fullName":5,"class":6},"Population Health Research Institute","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":35},[9],{"measure":10,"description":11,"timeFrame":12},"Major Bleeding","Major bleeding at 30 days, defined as bleeding that results in death and\u002For symptomatic bleeding in a critical area or organ, bleeding into a surgical site requiring reoperation, bleeding leading to hospitalization (including presentation to an acute care facility without overnight stay) and\u002For bleeding that causes a drop in the hemoglobin level of 20g\u002FL or more or that which requires the transfusion of ≥2 units of packed red blood cells or whole blood (as defined by the International Society of Thrombosis and Hemostasis)","30-Days post-randomization",[14,18,20,22,24,26,28,30,32],{"measure":15,"description":16,"timeFrame":17},"Composite of stroke and non-central nervous system systemic arterial embolism at 30 and 90 days.",null,"30-Days and 90-Days post-randomization",{"measure":10,"description":16,"timeFrame":19},"90-Days post-randomization",{"measure":21,"description":16,"timeFrame":17},"Pleural or pericardial effusion requiring drainage",{"measure":23,"description":16,"timeFrame":17},"Systemic arterial embolism",{"measure":25,"description":16,"timeFrame":17},"Ischemic stroke",{"measure":27,"description":16,"timeFrame":17},"Deep vein thrombosis",{"measure":29,"description":16,"timeFrame":17},"Pulmonary Embolism",{"measure":31,"description":16,"timeFrame":17},"Length of post-operative hospital stay",{"measure":33,"description":16,"timeFrame":34},"All-Cause Mortality","6 Months post-randomization",[36,39,41,43,45,47,49,52,55,58,62,64,66],{"measure":37,"description":38,"timeFrame":17},"Minor Bleeding","Tertiary outcome",{"measure":40,"description":38,"timeFrame":17},"All bleeding (major plus minor)",{"measure":42,"description":16,"timeFrame":17},"Myocardial Infarction",{"measure":44,"description":38,"timeFrame":17},"Valve Thrombosis",{"measure":46,"description":38,"timeFrame":17},"Hemorrhagic stroke",{"measure":48,"description":38,"timeFrame":17},"All Stroke",{"measure":50,"description":51,"timeFrame":17},"All Arterial Thrombosis\u002Fthromboembolism","Tertiary outcome: ischemic stroke, systemic arterial embolism, myocardial infarction, valve thrombosis",{"measure":53,"description":54,"timeFrame":17},"Quality of Life - EQ-5D-5L","Tertiary outcome: Measured by The EQ-5D-5L Questionnaire",{"measure":56,"description":57,"timeFrame":17},"Patient Satisfaction with Anticoagulant treatment","Tertiary outcome: Assessed by the Perception of Anticoagulant Treatment Questionnaire",{"measure":59,"description":60,"timeFrame":61},"Subclinical Valve Thrombosis on CT scan","Substudy outcome","60 to 90-Days post-randomization",{"measure":63,"description":60,"timeFrame":61},"Mean Aortic Valve g=Gradient on echocardiogram",{"measure":65,"description":60,"timeFrame":61},"Aortic Valve Reintervention",{"measure":67,"description":16,"timeFrame":68},"Association between subclinical valve thrombosis and clinically significant aortic valve thrombosis, stroke or systemic embolism","90 days",{"allocation":70,"interventionModel":71,"interventionModelDescription":16,"primaryPurpose":72,"observationalModel":16,"timePerspective":16,"maskingInfo":73},"RANDOMIZED","FACTORIAL","TREATMENT",{"masking":74,"maskingDescription":16,"whoMasked":16},"NONE","Approximately 36,000 Canadian adults undergo cardiac surgery annually. Of these patients, about 10% have a prior history of atrial fibrillation (AF). In the early post-operative period after cardiac surgery, 30-60% of patients develop AF and, by the time of discharge, 32% of patients who underwent cardiac surgery have an indication for oral anticoagulation (OAC). AF is associated with a significantly higher risk of stroke, even when transient, and OAC is the standard for thromboembolic prevention in these patients. In the post-operative period, the balance of benefits and risks of OAC may differ and the safest and most effective OAC in that patient population is uncertain.\n\nVitamin K antagonists (VKAs), such as warfarin or coumadin, are the most used anticoagulants after cardiac surgery. In the Left Atrial Appendage Occlusion Study (LAAOS) III that recruited 4811 patients from 105 centres in 27 countries, 77% of patients with AF on OAC were discharged on a VKA after cardiac surgery. Among patients taking a DOAC preoperatively, 55% were switched to a VKA after surgery. Over the first post-operative year, most of those patients were gradually transitioned back to a DOAC. Although effective, the use of VKAs is limited by a narrow therapeutic index requiring frequent international normalized ratio (INR) measurements to ensure appropriate levels of anticoagulation. This key limitation leads to non-compliance and discontinuation. In addition, in the first 3 months after cardiac surgery, time in the therapeutic range is low, even with close monitoring by experienced prescribers.\n\nIn the last decade, DOACs - inhibitors of factor Xa or thrombin- have become broadly used in patients with AF. Treatment with a DOAC in patients with AF has been demonstrated to yield a lower risk of stroke or systemic embolism and a similar risk of major bleeding when compared to VKAs during long-term follow-up. Moreover, DOACs are more convenient for both patients and clinicians. They have a rapid onset of effect, fixed dosage that obviates the need for regular monitoring, and few interactions with food and other medications. In the postoperative setting, DOACs may also lead to shorter length of stay and reduced costs.\n\nThe purpose of this study is to establish whether DOACs are as safe as VKAs in the first few weeks after heart surgery. The results of this study will impact the treatment of hundreds of thousands of patients in the world every year.\n\nA subset of 910 DANCE participants with a recent bioprosthetic aortic and\u002For mitral valve replacement will be enrolled in the SUNDANCE substudy (Subclinical valve thrombosis in patients with surgical bioprosthetic valve replacement: An imaging substudy of the DANCE trial). SUNDANCE will examine the effects of DOACs versus VKAs on subclinical valve thrombosis and bioprosthetic valve function by conducting computed tomography (CT) scans and echocardiograms at 60 to 90 days after randomization.",[77,83],{"label":78,"type":79,"description":80,"interventionNames":81},"Direct Oral Anticoagulation (DOAC)","ACTIVE_COMPARATOR","Patients in the intervention group will receive a DOAC at doses recommended for the indication, adjusted for their renal function is required. The choice of DOAC will be at the discretion of the treating physician.",[82],"Drug: DOAC",{"label":84,"type":85,"description":86,"interventionNames":87},"Vitamin K Antagonist","PLACEBO_COMPARATOR","Patients in the control group will receive VKA once daily; the individual dose will be titrated to achieve a guideline-recommended INR range.",[88],"Drug: VKA",[90,100],{"type":91,"name":92,"description":93,"armGroupLabels":94,"otherNames":95},"DRUG","DOAC","Patients will receive a DOAC at doses recommended for the indication, adjusted for their renal function is required. The choice of DOAC will be at the discretion of the treating physician.",[78],[96,97,98,99],"Apixaban","Dabigatran","Edoxaban","Rivaroxaban",{"type":91,"name":101,"description":86,"armGroupLabels":102,"otherNames":103},"VKA",[84],[104],"Warfarin",[106],{"name":107,"affiliation":108,"role":109},"Emilie Belley-Cote, MD, MSc","McMaster University","PRINCIPAL_INVESTIGATOR",[111,116],{"name":107,"role":112,"phone":113,"phoneExt":114,"email":115},"CONTACT","905-527-4322","40306","emilie.belley-cote@phri.ca",{"name":117,"role":112,"phone":113,"phoneExt":114,"email":118},"Richard Whitlock, MD, PhD","richard.whitlock@phri.ca",[120,138,152,168,181,195,206,219,232,243,256,266,280,286,299,311,324,333,346],{"facility":121,"status":122,"city":123,"state":124,"zip":125,"country":126,"countryCode":127,"cosmosGeoPoint":128,"geoPoint":133,"contacts":134},"St Vincent's Hospital Melbourne","RECRUITING","Fitzroy","Victoria","3065","Australia","AU",{"type":129,"coordinates":130},"Point",[131,132],144.97833,-37.79839,{"lat":132,"lon":131},[135,137],{"name":136,"role":112,"phone":16,"phoneExt":16,"email":16},"Andrew Newcomb, MD",{"name":136,"role":109,"phone":16,"phoneExt":16,"email":16},{"facility":139,"status":140,"city":141,"state":124,"zip":142,"country":126,"countryCode":127,"cosmosGeoPoint":143,"geoPoint":147,"contacts":148},"Royal Melbourne Hospital, University of Melbourne","NOT_YET_RECRUITING","Parkville","3050",{"type":129,"coordinates":144},[145,146],144.95,-37.78333,{"lat":146,"lon":145},[149,151],{"name":150,"role":112,"phone":16,"phoneExt":16,"email":16},"Alistair Royse, MD",{"name":150,"role":109,"phone":16,"phoneExt":16,"email":16},{"facility":153,"status":122,"city":154,"state":155,"zip":156,"country":157,"countryCode":158,"cosmosGeoPoint":159,"geoPoint":163,"contacts":164},"University of Alberta Hospital","Edmonton","Alberta","T6G 2C8","Canada","CA",{"type":129,"coordinates":160},[161,162],-113.46871,53.55014,{"lat":162,"lon":161},[165,167],{"name":166,"role":112,"phone":16,"phoneExt":16,"email":16},"Steven Meyer, MD",{"name":166,"role":109,"phone":16,"phoneExt":16,"email":16},{"facility":169,"status":122,"city":170,"state":171,"zip":172,"country":157,"countryCode":158,"cosmosGeoPoint":173,"geoPoint":177,"contacts":178},"University of British Columbia","Vancouver","British Columbia","V6T 1Z3",{"type":129,"coordinates":174},[175,176],-123.11934,49.24966,{"lat":176,"lon":175},[179],{"name":180,"role":109,"phone":16,"phoneExt":16,"email":16},"Erica Wang, PharmD",{"facility":182,"status":122,"city":183,"state":184,"zip":185,"country":157,"countryCode":158,"cosmosGeoPoint":186,"geoPoint":190,"contacts":191},"St. Boniface Hospital","Winnipeg","Manitoba","R2H 2A6",{"type":129,"coordinates":187},[188,189],-97.14704,49.8844,{"lat":189,"lon":188},[192,194],{"name":193,"role":112,"phone":16,"phoneExt":16,"email":16},"Michael Yamashita, MD",{"name":193,"role":109,"phone":16,"phoneExt":16,"email":16},{"facility":196,"status":197,"city":198,"state":199,"zip":200,"country":157,"countryCode":158,"cosmosGeoPoint":201,"geoPoint":205,"contacts":16},"Saint John Regional Hospital","ACTIVE_NOT_RECRUITING","Saint John","New Brunswick","E2L4L2",{"type":129,"coordinates":202},[203,204],-66.05616,45.27076,{"lat":204,"lon":203},{"facility":207,"status":122,"city":208,"state":209,"zip":210,"country":157,"countryCode":158,"cosmosGeoPoint":211,"geoPoint":215,"contacts":216},"Health Science Centre","St. John's","Newfoundland and Labrador","A1B 3V6",{"type":129,"coordinates":212},[213,214],-52.70931,47.56494,{"lat":214,"lon":213},[217],{"name":218,"role":109,"phone":16,"phoneExt":16,"email":16},"Hasib Hanif, MD",{"facility":220,"status":122,"city":221,"state":222,"zip":223,"country":157,"countryCode":158,"cosmosGeoPoint":224,"geoPoint":228,"contacts":229},"Health Sciences North Research Institute","Greater Sudbury","Ontario","P3E 5J1",{"type":129,"coordinates":225},[226,227],-80.99001,46.49,{"lat":227,"lon":226},[230],{"name":231,"role":109,"phone":16,"phoneExt":16,"email":16},"Bindu Bittira, MD",{"facility":233,"status":122,"city":234,"state":222,"zip":235,"country":157,"countryCode":158,"cosmosGeoPoint":236,"geoPoint":240,"contacts":241},"Hamilton General Hospital","Hamilton","L8L 2X2",{"type":129,"coordinates":237},[238,239],-79.84963,43.25011,{"lat":239,"lon":238},[242],{"name":107,"role":112,"phone":113,"phoneExt":114,"email":115},{"facility":244,"status":122,"city":245,"state":222,"zip":246,"country":157,"countryCode":158,"cosmosGeoPoint":247,"geoPoint":251,"contacts":252},"Sunnybrook Hospital","Toronto","M4N 3M5",{"type":129,"coordinates":248},[249,250],-79.39864,43.70643,{"lat":250,"lon":249},[253,255],{"name":254,"role":112,"phone":16,"phoneExt":16,"email":16},"Stephen Fremes, MD",{"name":254,"role":109,"phone":16,"phoneExt":16,"email":16},{"facility":257,"status":122,"city":245,"state":222,"zip":258,"country":157,"countryCode":158,"cosmosGeoPoint":259,"geoPoint":261,"contacts":262},"Toronto General Hospital","M5G 2C4",{"type":129,"coordinates":260},[249,250],{"lat":250,"lon":249},[263,265],{"name":264,"role":112,"phone":16,"phoneExt":16,"email":16},"Vivek Rao, MD",{"name":264,"role":109,"phone":16,"phoneExt":16,"email":16},{"facility":267,"status":122,"city":268,"state":269,"zip":270,"country":157,"countryCode":158,"cosmosGeoPoint":271,"geoPoint":275,"contacts":276},"Montreal Heart Institute","Montreal","Quebec","H1T 1C8",{"type":129,"coordinates":272},[273,274],-73.58781,45.50884,{"lat":274,"lon":273},[277,279],{"name":278,"role":112,"phone":16,"phoneExt":16,"email":16},"Philippe Demers, MD",{"name":278,"role":109,"phone":16,"phoneExt":16,"email":16},{"facility":281,"status":197,"city":268,"state":269,"zip":282,"country":157,"countryCode":158,"cosmosGeoPoint":283,"geoPoint":285,"contacts":16},"Hôpital Sacré-Coeur de Montréal","H4J1C5",{"type":129,"coordinates":284},[273,274],{"lat":274,"lon":273},{"facility":287,"status":122,"city":288,"state":269,"zip":289,"country":157,"countryCode":158,"cosmosGeoPoint":290,"geoPoint":294,"contacts":295},"IUCPQ-ULaval","Québec","G1V 4G5",{"type":129,"coordinates":291},[292,293],-71.21454,46.81228,{"lat":293,"lon":292},[296,298],{"name":297,"role":112,"phone":16,"phoneExt":16,"email":16},"Eric Dumont, MD",{"name":297,"role":109,"phone":16,"phoneExt":16,"email":16},{"facility":300,"status":197,"city":301,"state":302,"zip":303,"country":304,"countryCode":305,"cosmosGeoPoint":306,"geoPoint":310,"contacts":16},"Heart Center Leipzig","Leipzig","Saxony","04289","Germany","DE",{"type":129,"coordinates":307},[308,309],12.37129,51.33962,{"lat":309,"lon":308},{"facility":312,"status":122,"city":313,"state":314,"zip":304,"country":304,"countryCode":305,"cosmosGeoPoint":315,"geoPoint":319,"contacts":320},"University Hospital Jena","Jena","Thuringia",{"type":129,"coordinates":316},[317,318],11.5899,50.92878,{"lat":318,"lon":317},[321,323],{"name":322,"role":112,"phone":16,"phoneExt":16,"email":16},"Torsten Doenst, MD, PhD",{"name":322,"role":109,"phone":16,"phoneExt":16,"email":16},{"facility":325,"status":197,"city":326,"state":16,"zip":327,"country":304,"countryCode":305,"cosmosGeoPoint":328,"geoPoint":332,"contacts":16},"University Hospital Bonn Heart Center","Bonn","53127",{"type":129,"coordinates":329},[330,331],7.09549,50.73438,{"lat":331,"lon":330},{"facility":334,"status":140,"city":335,"state":16,"zip":336,"country":304,"countryCode":305,"cosmosGeoPoint":337,"geoPoint":341,"contacts":342},"West-German Heart and Vascular Center, University of Duisburg-Essen","Essen","45147",{"type":129,"coordinates":338},[339,340],7.01228,51.45657,{"lat":340,"lon":339},[343,345],{"name":344,"role":112,"phone":16,"phoneExt":16,"email":16},"Matthias Thielmann, MD, PhD",{"name":344,"role":109,"phone":16,"phoneExt":16,"email":16},{"facility":347,"status":122,"city":348,"state":16,"zip":349,"country":304,"countryCode":305,"cosmosGeoPoint":350,"geoPoint":354,"contacts":355},"University Medical Center Hamburg-Eppendorf","Hamburg","20246",{"type":129,"coordinates":351},[352,353],9.99302,53.55073,{"lat":353,"lon":352},[356,358],{"name":357,"role":112,"phone":16,"phoneExt":16,"email":16},"Simon Pecha, MD",{"name":357,"role":109,"phone":16,"phoneExt":16,"email":16},{"type":360,"investigatorFullName":16,"investigatorTitle":16,"investigatorAffiliation":16,"oldNameTitle":16,"oldOrganization":16},"SPONSOR",[362],{"name":363,"class":6},"Hamilton Health Sciences Corporation","100384372",false,"NCT04284839","The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial","DANCE","Inclusion Criteria:\n\n1. Age ≥18 years at the time of enrolment,\n2. Open heart surgery in the last 10 days,\n3. Atrial fibrillation requiring anticoagulation (including pre-existing or post-operative atrial fibrillation),\n4. Informed consent from either the patient or a substitute decision-maker.\n\nExclusion Criteria:\n\n1. Mechanical valve replacement,\n2. Antiphospholipid syndrome (triple positive),\n3. Severe renal failure (Cockcroft-Gault equation; creatinine clearance \\\u003C15 ml\u002Fmin),\n4. Known significant liver disease (Child-Pugh classification B and C),\n5. Left ventricular thrombus,\n6. Ongoing bleeding, hemorrhagic disorders, or bleeding diathesis,\n7. Known contraindication for any DOAC or VKA,\n8. Women who are pregnant, breastfeeding, or of childbearing potential,\n9. Surgery including left ventricular assist device implantation or cardiac transplantation,\n10. Previously enrolled in this trial,\n11. Follow-up not possible,\n12. History of moderate or severe mitral valvular lesion (stenosis or regurgitation) that is not corrected during index cardiac surgery.","ALL","18 Years",{"count":373,"type":374},3500,"ESTIMATED","INTERVENTIONAL",[377],"PHASE3","The DANCE Trial is a multi-centre, randomized controlled trial comparing the safety of direct oral anticoagulants (DOAC) versus vitamin K antagonists (VKA) in the early period (30 days) after cardiac surgery in patients with atrial fibrillation requiring oral anticoagulation.",[380,381],"Bleeding Post Cardiac Surgery","Indication for Anticoagulation",[383,84,384],"Direct Oral Anticoagulant","Bleeding","2025-09-23",{"date":387,"type":388},"2025-09-29","ACTUAL",{"date":390,"type":388},"2021-07-18",{"date":392,"type":374},"2027-06",{"name":5,"class":6},19]